AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $290,000 | -45.7% | 7,000 | -50.5% | 0.01% | -41.7% |
| Q4 2021 | $534,000 | -6.2% | 14,139 | -18.1% | 0.01% | 0.0% |
| Q3 2021 | $569,000 | -35.2% | 17,266 | +32.7% | 0.01% | -36.8% |
| Q2 2021 | $878,000 | +23.5% | 13,015 | +3.7% | 0.02% | +18.8% |
| Q1 2021 | $711,000 | -33.2% | 12,550 | -3.9% | 0.02% | -23.8% |
| Q4 2020 | $1,064,000 | +49.2% | 13,063 | +30.6% | 0.02% | +10.5% |
| Q3 2020 | $713,000 | +73.5% | 10,000 | +100.0% | 0.02% | +58.3% |
| Q2 2020 | $411,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |